Zika Virus 2018 Global Market Outlook,Research,Trends and Forecast to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Zika Virus 2018 Global Market Outlook,Research,Trends and Forecast to 2023”.

Pune, India – July 13, 2018 /MarketersMedia/ —

Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections.

Scope of the Report:
This report focuses on the Zika Virus in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Zika virus is primarily transmitted to people through the bite of an infected mosquito from the Aedes genus, mainly Aedes aegypti in tropical regions. Sexual transmission of Zika virus is also possible. Other modes of transmission such as blood transfusion are being investigated.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3280680-global-north-america-europe-asia-pacific-south-america

For more information or any query mail at sales@wiseguyreports.com

Zika virus is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Outbreaks of Zika virus disease have been recorded in Africa, the Americas, Asia and the Pacific. From the 1960s to 1980s, human infections were found across Africa and Asia, typically accompanied by mild illness. The first large outbreak of disease caused by Zika infection was reported from the Island of Yap (Federated States of Micronesia) in 2007. In July 2015 Brazil reported an association between Zika virus infection and Guillain-Barré syndrome. In October 2015 Brazil reported an association between Zika virus infection and microcephaly.

The worldwide market for Zika Virus is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bharat Biotech

Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Sexual Transmission
Blood Transfusion

Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgery Centers
Others

Ask Query @ https://www.wiseguyreports.com/enquiry/3280680-global-north-america-europe-asia-pacific-south-america

Table Of Contents – Major Key Points

1 Market Overview
1.1 Zika Virus Introduction
1.2 Market Analysis by Type
1.2.1 Sexual Transmission
1.2.2 Blood Transfusion
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgery Centers
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Business Overview
2.1.1.1 Bharat Biotech Description
2.1.1.2 Bharat Biotech Headquarter, Main Business and Finance Overview
2.1.2 Bharat Biotech Zika Virus Product Introduction
2.1.2.1 Zika Virus Production Bases, Sales Regions and Major Competitors
2.1.2.2 Zika Virus Product Information
2.1.3 Bharat Biotech Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Bharat Biotech Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Bharat Biotech Zika Virus Market Share in 2017
2.2 Inovio Pharmaceuticals and GeneOne Life Sciences
2.2.1 Business Overview
2.2.1.1 Inovio Pharmaceuticals and GeneOne Life Sciences Description
2.2.1.2 Inovio Pharmaceuticals and GeneOne Life Sciences Headquarter, Main Business and Finance Overview
2.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Introduction
2.2.2.1 Zika Virus Production Bases, Sales Regions and Major Competitors
2.2.2.2 Zika Virus Product Information
2.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Market Share in 2017
2.3 Intrexon
2.3.1 Business Overview
2.3.1.1 Intrexon Description
2.3.1.2 Intrexon Headquarter, Main Business and Finance Overview
2.3.2 Intrexon Zika Virus Product Introduction
2.3.2.1 Zika Virus Production Bases, Sales Regions and Major Competitors
2.3.2.2 Zika Virus Product Information
2.3.3 Intrexon Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Intrexon Zika Virus Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Intrexon Zika Virus Market Share in 2017

Continued……

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/zika-virus-2018-global-market-outlookresearchtrends-and-forecast-to-2023/377687

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 377687

Go Top